Technology
Viewpoints
Filter by:
Mintz Venture Watch — Volume 7: A Report on Deal Trends from Q1 and Q2 2024
September 27, 2024 | Article | By Daniel DeWolf, Samuel Asher Effron, Jeremy Glaser
This edition of Mintz Venture Watch reports on the firm’s VC transaction activity in the first half of 2024. During this period, Mintz represented issuers and investors in the technology, life sciences, energy, and other sectors in 73 transactions valued at more than $980 million.
MintzTech Connect Industry News: Spotlight on GUDEA
September 18, 2024 | Article
Read about GUDEA, a technology company with AI-driven tools that enable organizations to predict, map, and influence information flows across social networks before they impact public perception.
Washington Shake-Up: Vice President Harris to Lead Democratic Nomination for 2024 Presidency
July 25, 2024 | Alert | By Pamela Mejia, R. Neal Martin
Read about President Biden’s recent withdrawal from the 2024 presidential election and his endorsement of Vice President Kamala Harris as the Democratic nominee, including her stance on technology, climate change, health care, and tax policy.
Colorado AI Systems Regulation: What Health Care Deployers and Developers Need to Know
June 27, 2024 | Blog | By Pat Ouellette
As the first state law to regulate the results of Artificial Intelligence System (AI System) use, Colorado’s SB24-205, “Concerning Consumer Protections in Interactions with Artificial Intelligence Systems” (the Act), has generated plenty of cross-industry interest, for good reason. In some ways similar to the risk-based approach taken by the European Union (EU) in the EU AI Act, the Act aims to regulate developers and deployers of AI Systems, which are defined by the Act as “any machine-based system that, for any explicit or implicit objective, infers from the inputs the system receives how to generate outputs, including content, decisions, predictions, or recommendations, that can influence physical or virtual environments.”
MintzTech Connect Event Highlight: The Sustainable Media Center
June 13, 2024 | Article
MintzTech Connect: All Things Technology — June 2024
June 13, 2024 | Article | By Daniel DeWolf, Samuel Asher Effron
This issue of MintzTech Connect covers the FTC’s controversial final rule banning most post-employment non-competes, qualified small business stock issues affecting the conversion of an LLC into a corporation, clinical trial innovator Radicle Science, and an event co-sponsored by Mintz and the Sustainable Media Center, which focused on the impact of social media on today’s youth.
MintzTech Connect Industry News: Spotlight on Radicle Science
June 13, 2024 | Article | By Jeremy Glaser, Sophia Fein
Read about Radicle Science, a B-corp transforming the supplement industry’s approach to clinical trials and efficacy validation through virtual trials that greatly expand the scale and diversity of trial participants.
MintzTech Connect: All Things Technology — March 2024
March 20, 2024 | Article | By Daniel DeWolf, Samuel Asher Effron
This issue of MintzTech Connect covers Corporate Transparency Act compliance requirements, considerations for companies undertaking Section 409A valuations, and Mintz’s year in review of laws impacting employee non-competition, non-solicitation, and non-disclosure agreements.
Mintz Venture Watch — Volume 6: A Report on Deal Trends from 2023
February 6, 2024 | Article | By Daniel DeWolf, Samuel Asher Effron, Jeremy Glaser
This edition of Mintz Venture Watch reports on the firm’s VC transaction activity in 2023. Mintz represented issuers and investors in the technology, energy, life sciences, and other sectors in more than 130 transactions valued at over $2.6 billion.
HHS, ONC HTI-1 Final Rule Introduces New Transparency Requirements for Artificial Intelligence in Certified Health IT
January 8, 2024 | Blog | By Pat Ouellette
The Department of Health and Human Services (HHS) was tasked with formalizing and coordinating efforts to regulate artificial intelligence (AI) in health care under the November 2023 Executive Order on the Safe, Secure, and Trustworthy Development and Use of Artificial Intelligence (AI EO) and has already begun its regulation of AI within certain certified health IT. HHS and Office of the National Coordinator for Health Information Technology (ONC) recently published the Health Data, Technology, and Interoperability: Certification Program Updates, Algorithm Transparency, and Information Sharing (HTI-1) Final Rule.
MintzTech Connect: All Things Technology — December 2023
December 15, 2023 | Article | By Daniel DeWolf, Samuel Asher Effron
This issue of MintzTech Connect covers a Globe and Mail piece on Mintz’s continued expansion in Toronto, Biden’s executive order on artificial intelligence, Forbes magazine’s recognition of Moolah Kicks founder Natalie White’s inclusion on its “30 Under 30” list, and our Client Corner podcast featuring a conversation with NextGen Jane Co-founder & CEO Ridhi Tariyal.
MintzTech Connect Client Spotlight: Moolah Kicks Founder Natalie White Recognized as a “30 Under 30” by Forbes
December 15, 2023 | Article | By Daniel DeWolf, Samuel Asher Effron
As reported in Forbes, Natalie White was recognized as a “30 under 30” for Sports. Natalie founded Moolah Kicks, the first basketball shoe brand focused solely on women.
Federal Trade Commission Supercharges AI Regulatory Powers — AI: The Washington Report
November 30, 2023 | Article | By Bruce Sokler, Alexander Hecht, Christian Tamotsu Fjeld, Raj Gambhir
Read about the FTC’s preauthorization of a compulsory process in investigations relating to AI and a new AI bill supported by a bipartisan group of Commerce Committee senators in the latest edition of AI: The Washington Report, a joint undertaking of Mintz and ML Strategies covering potential federal legislative, executive, and regulatory activities related to AI.
Biden Executive Order Calls for HHS to Establish Health Care-Specific Artificial Intelligence Programs and Policies
November 2, 2023 | Blog | By Pat Ouellette, Lara Compton, Madison Castle
On October 30, 2023, the Biden Administration released and signed an Executive Order on the Safe, Secure, and Trustworthy Development and Use of Artificial Intelligence (Executive Order) that articulates White House priorities and policies related to the use and development of artificial intelligence (AI) across different sectors, including health care.
Mintz and Antler: A Game-Changing Partnership Boosting Legal Support for Startups Everywhere — Including Innovative Health Care Company “peri”
September 12, 2023 | Article | By Stephen Osborn
Read about how Mintz’s partnership with startup accelerator and venture capital firm Antler led to Mintz’s work for oral health innovator peri.
MintzTech Connect Industry News: Spotlight on mePrism
September 12, 2023 | Article | By Samuel Asher Effron
Read about mePrism, a technology company that helps customers remove their personal information from the internet.
MintzTech Connect: All Things Technology — September 2023
September 12, 2023 | Article | By Daniel DeWolf, Samuel Asher Effron
This issue of MintzTech Connect covers QSBS issues related to converting an LLC into a corporation, legal decisions regarding cryptocurrencies and whether they are subject to SEC regulation, how Mintz’s partnership with Antler led to our work for oral health innovator peri, and a spotlight on mePrism, a tech company that helps customers remove their personal information from the internet.
Mintz Venture Watch — Volume 5: A Report on Deal Trends from Q1 and Q2 2023
August 21, 2023 | Article | By Daniel DeWolf, Lewis Geffen, Jeremy Glaser
Despite choppy market conditions for private companies, the Mintz Venture Capital & Emerging Companies team remained busy advising emerging companies of all sizes and at all stages of growth across a wide range of industries. For the first half of 2023 we completed 72 transactions, with an aggregate deal value in excess of $1.6 billion. Below are a few highlighted transactions:
MintzTech Connect: All Things Technology — May 2023
May 24, 2023 | Article | By Daniel DeWolf, Samuel Asher Effron
Spring is in the air but it is a challenging time to understand which way the wind is blowing on the emerging companies space. On the one hand, we saw a pause in investment activity at the end of 2022 and the first few months in 2023. On the other hand, we have seen a noticeable uptick of investment activity in the last six weeks. Again, on the one hand (a different set of hands) we recently saw a significant market correction in terms of valuations. But on the other hand, we have not seen a lot of the more punitive investment terms such as multiple participating preferences or pay to play provisions that we witnessed in the great recession in 2009 and the post bubble period in 2001.
Explore Other Viewpoints:
- AI: The Washington Report
- Antitrust
- Appellate
- Arbitration, Mediation & Alternate Dispute Resolution
- Artificial Intelligence
- Awards
- Bankruptcy & Restructuring
- California Land Use
- Class Action
- Complex Commercial Litigation
- Construction
- Consumer Product Safety
- Corporate Governance (ESG)
- Cross-Border Asset Recovery
- Debt Financing
- Direct Investing (M&A)
- Diversity
- EB-5 Financing
- Education & Nonprofits
- Election 2024
- Employment
- Energy & Sustainability
- Environmental (ESG)
- Environmental Enforcement Defense
- Environmental Law
- Environmental, Social, and Corporate Governance (ESG)
- FDA Regulatory
- False Claims Act
- Federal Circuit Appeals
- Financial Institution Litigation
- Government Law
- Growth Equity
- Health Care
- Health Care Compliance, Fraud and Abuse, & Regulatory Counseling
- Health Care Enforcement & Investigations
- Health Care Transactions
- Health Information Privacy & Security
- IP Due Diligence
- IPRs & Other Post Grant Proceedings
- Immigration
- Insolvency & Creditor Rights Litigation
- Institutional Investor Class Action Recovery
- Insurance & Financial Services
- Insurance Consulting & Risk Management
- Insurance and Reinsurance Problem-Solving & Dispute Resolution
- Intellectual Property
- Investment Funds
- Israel
- Licensing & Technology Transactions
- Life Sciences
- Litigation & Investigations
- M&A Litigation
- ML Strategies
- Medicare, Medicaid and Commercial Coverage & Reimbursement
- Mergers & Acquisitions
- Patent Litigation
- Patent Prosecution & Strategic Counseling
- Pharmacy Benefits and PBM Contracting
- Portfolio Companies
- Privacy & Cybersecurity
- Private Client
- Private Equity
- Pro Bono
- Probate & Fiduciary Litigation
- Products Liability & Complex Tort
- Projects & Infrastructure
- Public Finance
- Real Estate Litigation
- Real Estate Transactions
- Real Estate, Construction & Infrastructure
- Retail & Consumer Products
- Securities & Capital Markets
- Securities Litigation
- Social (ESG)
- Special Purpose Acquisition Company (SPACs)
- Sports & Entertainment
- State Attorneys General
- Strategic IP Monetization & Licensing
- Tax
- Technology
- Technology, Communications & Media
- Technology, Communications & Media Litigation
- Trade Secrets
- Trademark & Copyright
- Trademark Litigation
- Value-Based Care
- Venture Capital & Emerging Companies
- White Collar Defense & Government Investigations
- Women's Health and Technology